AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,024.00p
   
  • Change Today:
      36.00p
  • 52 Week High: 12,488.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 3,697,512
  • Market Cap: £186,399m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
08-Mar-24 Transfer From Pascal Soriot 0.000p 105,238 £0.00
20-Feb-24 Transfer From Pascal Soriot 0.000p 12,345 £0.00
12-Dec-23 Buy Anna Manz 10,189.56p 487 £49,623.16
22-Nov-23 Buy Michel Demare 10,170.00p 1,000 £101,700.00
21-Nov-23 Buy Michel Demare 10,105.22p 1,000 £101,052.24
05-May-23 Sell Aradhana Sarin 11,844.90p 9,735 £1,153,100.69

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,024.00p
Change Today 36.00p
% Change 0.30 %
52 Week High 12,488.00
52 Week Low 9,501.00
Volume 3,697,512
Shares Issued 1,550.22m
Market Cap £186,399m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.34% below the market average92.34% below the market average92.34% below the market average92.34% below the market average92.34% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
60.23% above the market average60.23% above the market average60.23% above the market average60.23% above the market average60.23% above the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Income
91.98% below the market average91.98% below the market average91.98% below the market average91.98% below the market average91.98% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
82.39% above the market average82.39% above the market average82.39% above the market average82.39% above the market average82.39% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 29-Apr-2024

Time Volume / Share Price
09:00 500 @ 12,086.00p
09:23 500 @ 12,080.00p
16:17 0 @ 12,030.00p
16:20 0 @ 12,028.00p
16:16 0 @ 12,022.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page